Catalyst Pharmaceuticals (CPRX) EPS (Weighted Average and Diluted) (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.95% |
| Dec 31, 2025 | -2.38% |
| Sep 30, 2025 | 2.44% |
| Jun 30, 2025 | -8.89% |
| Mar 31, 2025 | 2.27% |
| Dec 31, 2024 | 25.71% |
| Sep 30, 2024 | 6.06% |
| Jun 30, 2024 | 73.68% |
| Mar 31, 2024 | -38.71% |
| Dec 31, 2023 | 206.90% |
| Sep 30, 2023 | -187.88% |
| Jun 30, 2023 | 26.92% |
| Mar 31, 2023 | 13.04% |
| Dec 31, 2022 | 15.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 66.67% |
| Mar 31, 2022 | 33.33% |
| Dec 31, 2021 | -10.00% |
| Sep 30, 2021 | -9.09% |
| Jun 30, 2021 | 57.14% |
| Mar 31, 2021 | -36.36% |
| Dec 31, 2020 | -73.17% |
| Sep 30, 2020 | 355.56% |
| Jun 30, 2020 | -10.00% |
| Mar 31, 2020 | 42.86% |
| Dec 31, 2019 | -46.15% |
| Sep 30, 2019 | 30.00% |
| Jun 30, 2019 | 1,100.00% |
| Mar 31, 2019 | 92.86% |
| Dec 31, 2018 | -75.00% |
| Sep 30, 2018 | -33.33% |